echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Diagn Pathol: The Treg/Th17 ratio can be used as a potential marker for predicting insanity cirrhosis.

    Diagn Pathol: The Treg/Th17 ratio can be used as a potential marker for predicting insanity cirrhosis.

    • Last Update: 2020-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recent studies have shown that T-cell-mediated cellular immune mechanisms play an important role in the progression of hepatitis B into cirrhosis, but their basic mechanisms are still unclear.
    study aims to determine the relationship between Treg/Th17 and hepatitis B-related cirrhosis, the findings have been published online in Diagn Pathol.
    used a flow cytometer to determine the frequency of Treg and Th17 cells in the outer blood of all participants, including 93 patients with hepatitis B-related cirrhosis and 40 healthy people.
    study the prognostic significance of Treg/Th17 ratio to non-compensation cirrhosis by applying Cox regression model and subject working characteristic curve.
    results showed that patients with hepatitis B-related cirrhosis had a Treg/Th17 imbalance, with fewer Treg cells in their outer blood, an increase in Th17 cells, and a decrease in the Treg/Th17 ratio.
    treg and Th17 cells were negatively related.
    TheTreg/Th17 imbalance was closely related to the clinical stage of hepatitis B-related cirrhosis.
    the Cox regression model, viral load, Treg frequency, and Treg/Th17 ratio are independent factors in predicting insanity cirrhosis.
    ROC analysis showed that the Treg/Th17 ratio was the best marker for predicting non-compensation cirrhosis.
    , the results show that the Treg/Th17 imbalance is involved in the pathogenesis of hepatitis B-related cirrhosis, and the Treg/Th17 ratio can be used as a potential marker for predicting unresoconsced cirrhosis.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.